TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients
Status:
Recruiting
Trial end date:
2029-09-30
Target enrollment:
Participant gender:
Summary
To offer the possibility of a treatment that could achieve a meaningful reduction in the
incidence of post-radiation therapy hypothyroidism. Thyroid dysfunction may develop from a
few months to several years after patients have completed their radiation treatment. In
children with chronic diseases, or given lengthy anti-neoplastic treatments, recurrent or
persistent endocrine disorders may have a negative effect on growth and development into
adulthood.
Phase:
Phase 3
Details
Lead Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano